Brief: Acer Therapeutics Regains Compliance With Nasdaq Listing Standard
31/03/2022 14:07
March 31 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ LISTING
STANDARD
Source text for Eikon: ID:nGNX2zNzGX
Further company coverage: ACER.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31